Document is current
Any future updates will be listed below
-
Authors
Mohan, Mahendra K. https://orcid.org/0000-0002-6827-592X
Thorat, Ketan https://orcid.org/0000-0001-8501-4855
Puthiyapurayil, Theja Parassini https://orcid.org/0009-0002-1620-6049
Sunnapu, Omprakash https://orcid.org/0000-0003-1940-7188
Chandrashekharappa, Sandeep https://orcid.org/0000-0003-2475-7270
Ravula, Venkatesh https://orcid.org/0000-0002-0229-7640
Khader, Rajamohammed https://orcid.org/0009-0002-6902-381X
Sankaranarayanan, Aravind https://orcid.org/0000-0002-5832-6770
Muhammad, Hadi https://orcid.org/0009-0008-7774-8240
Vemula, Praveen Kumar https://orcid.org/0000-0003-0279-4230
- License Information
-
More Information
Article History
Received: 18 October 2023
Accepted: 23 May 2024
First Online: 6 June 2024
Competing interests
: P.K.V., K.T., and S.C. hold patents related to this technology: “Composition, materials, and methods for deactivating toxic agents” (Granted Indian patent: 201841006678 and granted Sri Lankan Patent # 20419). All compositions and methods of use described in this manuscript were covered in the patent applications. P.K.V., K.T., and S.C. are inventors of patents that were licensed to Sepio Health, a company that has licensed IP generated by P.K.V., K.T., and S.C., that may benefit financially if the IP is further validated. The interests of P.K.V. were reviewed and are subject to a management plan overseen by his institution in accordance with its conflict of interest policies. P.K.V. and O.S. are equity holders in Sepio Health. The remaining authors declare no competing interests.
